130 related articles for article (PubMed ID: 27449203)
1. Hippocampal Aβ expression, but not phosphorylated tau, predicts cognitive deficits following repeated peripheral poly I:C administration.
White JD; Eimerbrink MJ; Hayes HB; Hardy A; Van Enkevort EA; Peterman JL; Chumley MJ; Boehm GW
Behav Brain Res; 2016 Oct; 313():219-225. PubMed ID: 27449203
[TBL] [Abstract][Full Text] [Related]
2. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
3. Peripheral administration of poly I:C leads to increased hippocampal amyloid-beta and cognitive deficits in a non-transgenic mouse.
Weintraub MK; Kranjac D; Eimerbrink MJ; Pearson SJ; Vinson BT; Patel J; Summers WM; Parnell TB; Boehm GW; Chumley MJ
Behav Brain Res; 2014 Jun; 266():183-7. PubMed ID: 24631395
[TBL] [Abstract][Full Text] [Related]
4. Imatinib methanesulfonate reduces hyperphosphorylation of tau following repeated peripheral exposure to lipopolysaccharide.
Gardner LE; White JD; Eimerbrink MJ; Boehm GW; Chumley MJ
Neuroscience; 2016 Sep; 331():72-7. PubMed ID: 27320209
[TBL] [Abstract][Full Text] [Related]
5. The α5-GABA
Eimerbrink MJ; Pendry RJ; Hodges SL; Wiles JD; Peterman JL; White JD; Hayes HB; Chumley MJ; Boehm GW
Behav Brain Res; 2019 Feb; 359():871-877. PubMed ID: 30031883
[TBL] [Abstract][Full Text] [Related]
6. Hypercholesterolemia accelerates amyloid β-induced cognitive deficits.
Park SH; Kim JH; Choi KH; Jang YJ; Bae SS; Choi BT; Shin HK
Int J Mol Med; 2013 Mar; 31(3):577-82. PubMed ID: 23314909
[TBL] [Abstract][Full Text] [Related]
7. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.
Dobarro M; Gerenu G; Ramírez MJ
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694
[TBL] [Abstract][Full Text] [Related]
8. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
Zhang ZX; Zhao RP; Wang DS; Wang AN
Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601
[TBL] [Abstract][Full Text] [Related]
9. Notopterygium incisum extract (NRE) rescues cognitive deficits in APP/PS1 Alzhneimer's disease mice by attenuating amyloid-beta, tau, and neuroinflammation pathology.
Jiang XW; Liu WW; Wu YT; Wu Q; Lu HY; Xu ZH; Gao HY; Zhao QC
J Ethnopharmacol; 2020 Mar; 249():112433. PubMed ID: 31783135
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation.
Park SH; Kim JH; Bae SS; Hong KW; Lee DS; Leem JY; Choi BT; Shin HK
Biochem Biophys Res Commun; 2011 May; 408(4):602-8. PubMed ID: 21530492
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice.
Zhou D; Liu H; Li C; Wang F; Shi Y; Liu L; Zhao X; Liu A; Zhang J; Wang C; Chen Z
Metab Brain Dis; 2016 Jun; 31(3):693-703. PubMed ID: 26883430
[TBL] [Abstract][Full Text] [Related]
12. Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.
Gasparotto J; Girardi CS; Somensi N; Ribeiro CT; Moreira JCF; Michels M; Sonai B; Rocha M; Steckert AV; Barichello T; Quevedo J; Dal-Pizzol F; Gelain DP
J Biol Chem; 2018 Jan; 293(1):226-244. PubMed ID: 29127203
[TBL] [Abstract][Full Text] [Related]
13. Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy.
Huber CM; Yee C; May T; Dhanala A; Mitchell CS
J Alzheimers Dis; 2018; 61(1):265-281. PubMed ID: 29154274
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide exposure in a rat sepsis model results in hippocampal amyloid-β plaque and phosphorylated tau deposition and corresponding behavioral deficits.
Kirk RA; Kesner RP; Wang LM; Wu Q; Towner RA; Hoffman JM; Morton KA
Geroscience; 2019 Aug; 41(4):467-481. PubMed ID: 31473912
[TBL] [Abstract][Full Text] [Related]
15. Activation of mTOR signaling leads to orthopedic surgery-induced cognitive decline in mice through β-amyloid accumulation and tau phosphorylation.
Shen W; Lu K; Wang J; Wu A; Yue Y
Mol Med Rep; 2016 Oct; 14(4):3925-34. PubMed ID: 27599409
[TBL] [Abstract][Full Text] [Related]
16. Imatinib methanesulfonate reduces hippocampal amyloid-β and restores cognitive function following repeated endotoxin exposure.
Weintraub MK; Bisson CM; Nouri JN; Vinson BT; Eimerbrink MJ; Kranjac D; Boehm GW; Chumley MJ
Brain Behav Immun; 2013 Oct; 33():24-8. PubMed ID: 23665252
[TBL] [Abstract][Full Text] [Related]
17. Prolonged elevation in hippocampal Aβ and cognitive deficits following repeated endotoxin exposure in the mouse.
Kahn MS; Kranjac D; Alonzo CA; Haase JH; Cedillos RO; McLinden KA; Boehm GW; Chumley MJ
Behav Brain Res; 2012 Apr; 229(1):176-84. PubMed ID: 22249135
[TBL] [Abstract][Full Text] [Related]
18. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
[TBL] [Abstract][Full Text] [Related]
19. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
[TBL] [Abstract][Full Text] [Related]
20. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]